Show newer

RT @VTrillet_Lenoir: 💊Visite du siège @EMA_News à Amsterdam aujourd’hui.

👏🏻Merci aux équipes pour les fructueux échanges autour de la lutte contre les pénuries de médicaments, la résistance aux antibiotiques et les priorités de la future révision de la législation pharmaceutique européenne.

🐦🔗: n.respublicae.eu/EMA_News/stat

RT @HardemanHildeML: Very pleased we’re able to invite you to ! Join us to discuss the force and the potential of multilingual reference data and semantic technologies ... in the information we provide to the public and in our everyday lives.

Register soon! op.europa.eu/en/web/endorse?pk

🐦🔗: n.respublicae.eu/EMA_News/stat

Congratulations to our Executive Director, Emer Cooke, for this award!
RT @emireland: Today, we honour Emer Cooke as the European of the Year.

This is her story and the story of our prestigious award.

📽️: youtube.com/watch?v=l0UAXR1ywi

🏆 | @EMA_News

🐦🔗: n.respublicae.eu/EMA_News/stat

EMA recommended 8⃣9⃣ human for marketing authorisation in 2022.

4⃣1⃣ had a new active substance which had never been authorised in the 🇪🇺 before.

Consult our annual human medicines highlights: ema.europa.eu/en/news/human-me

🐦🔗: n.respublicae.eu/EMA_News/stat

EMA recommended 1⃣0⃣ for marketing authorisation in 2022. 🐈🐖🐎

3⃣ had a new active substance.

2⃣ were vaccines, including one new biotechnological vaccine.💉

Don’t miss our annual veterinary medicines highlights: ema.europa.eu/en/news/veterina

🐦🔗: n.respublicae.eu/EMA_News/stat

EMA recommended 8⃣9⃣ human for marketing authorisation in 2022.

4⃣0⃣ had a new active substance which had never been authorised in the 🇪🇺 before.

Consult our annual human medicines highlights: ema.europa.eu/en/news/human-me

🐦🔗: n.respublicae.eu/EMA_News/stat

RT @EatrisEric: 🚀 The new “Cell & Gene Therapy Development” course is now available! 30 months of the @ADVANCE_atmp project has resulted in material for an online course with 12 speakers, 4 learning units, & more!

👉 Find out more here: eatris.eu/news/game-changing-c

🐦🔗: n.respublicae.eu/EMA_News/stat

What is the therapeutic potential of especially for the treatment of diseases?

Read the new @TheLancet article which presents a European regulatory perspective on psychedelics: thelancet.com/journals/lancet/

🐦🔗: n.respublicae.eu/EMA_News/stat

RT @EC_HERA: to the conference in December.

Check out the video for souvenirs of the day, as well as some key takes.

Part deux coming soon 😉🥳

🐦🔗: n.respublicae.eu/EMA_News/stat

RT @ECDC_EU: Here’s to the at the working for a safer 🇪🇺 – evaluation of medicines, disease control, environmental science, food & chemical safety.

Get inspired by their stories in this thread. 🧵

Meet Anastasia Pharris from .
(1/7)

🐦🔗: n.respublicae.eu/EMA_News/stat

@EFSA_EU @EU_ECHA @euenvironment @ECDC_EU @GallaniBarbara Meet Kristina Larsson from .

She is Head of orphan medicines, medicines developed to treat certain that affect no more than 5 in 10,000 people in the 🇪🇺 .

5/7 ⤵️

🐦🔗: n.respublicae.eu/EMA_News/stat

📢New public consultation open!
EMA, the Heads of Medicines Agencies and the @EU_Commission want to hear your views on the establishment of a multi-stakeholder platform to improve in the 🇪🇺.
Read more 👇
ema.europa.eu/en/news/public-c

🐦🔗: n.respublicae.eu/EMA_News/stat

Show older
Mastodon

A Mastodon forum for the discussion of European Union matters. Not run by the EU. Powered by PleromaBot, Nitter and PrivacyDev.net.